8-K
Current Report
4D Molecular Therapeutics, Inc. Filed Acc 0001564590-21-034575
Agreement ended · Other events
- Item 1.02 Termination of a material definitive agreement
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading fdmt-8k_20210618.htm…